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The basic Helix-Loop-Helix (bHLH) proteins represent a well-known class of transcriptional regulators. Many
bHLH proteins act as heterodimers with members of a class of ubiquitous partners, the E proteins. A widely
expressed class of inhibitory heterodimer partners—the Inhibitor of DNA-binding (ID) proteins—also exists.
Genetic and molecular analyses in humans and in knockout mice implicate E proteins and ID proteins in a
wide variety of diseases, belying the notion that they are non-specific partner proteins. Here, we explore
relationships of E proteins and ID proteins to a variety of disease processes and highlight gaps in knowledge
of disease mechanisms.E proteins and Inhibitor of DNA-binding (ID) proteins are widely
expressed transcriptional regulators with very general functions.
They are implicated in diseases by evidence ranging from
confirmed Mendelian inheritance, association studies, and
mouse models that resemble human disorders. Here, we briefly
recap the properties of E proteins and ID proteins in develop-
ment and differentiation, cell proliferation, and cancer that
have been gleaned from decades of study (Massari and Murre,
2000; Murre, 2005; Belle and Zhuang, 2014; Lasorella et al.,
2014; Ling et al., 2014; Nair et al., 2014), before describing dis-
ease associations where the mechanisms of E protein and ID
protein contributions are incompletely understood.
HLH Proteins in Differentiation
The helix-loop-helix (HLH) domain was first recognized in
dimeric transcription factors that regulate the IgG enhancer in
B cells. Since these bind to Ephrussi-box (E-box) sequences
(CANNTG), the first HLH proteins were named E proteins (Murre
et al., 1989). Mammalian E proteins include E12 and E47, which
arise through alternative splicing of the E2A (HGNC:11633) gene,
E2-2 (HGNC:11634), and HEB (HGNC:11623). Renaming these
proteins TCF3, TCF4, and TCF12, respectively, has been sug-
gested (Table 1), but caution must be used to avoid confusion
since the acronym TCF had already been assigned to unrelated
proteins. There is a single E protein in Drosophila, the Daughter-
less (Da) protein.
E proteins have many functions as heterodimer partners of the
tissue-specific basic Helix-Loop-Helix (bHLH) proteins that are
sometimes called class II bHLH proteins. The diverse class II
bHLH proteins include the myogenic transcription factors exem-
plified by MYOD, a factor sufficient to transform cultured fibro-
blasts into myoblasts, the conserved proneural proteins such
as Achaete and Scute from Drosophila, and hematopoiesis pro-
tein T cell acute lymphocytic leukemia 1 (TAL1) (Massari and
Murre, 2000; Powell and Jarman, 2008). The paradigm that
was soon established is that tissue-specific class II bHLH factors
whose specific expression defines specification and differentia-
tion programs such as myogenesis or neurogenesis act byconferring DNA-binding specificity and transcriptional activation
on heterodimers with the ubiquitous E proteins (Figure 1).
Another class of pervasive HLH proteins acts in opposition to
E proteins. These ID proteins lack a basic DNA-binding region so
that heterodimers of ID proteins with E proteins or with class II
bHLH proteins are unable to bind DNA or activate transcription
(Benezra et al., 1990). ID protein levels may be low in differenti-
ated cells but are abundant in proliferating, multipotent cells
including stem cell populations (Ling et al., 2014). Like the E pro-
teins, ID proteins are represented by a single homolog in
Drosophila, the extra macrochaetae (emc) gene, which was iden-
tified in parallel with mammalian ID proteins. emc encodes a
negative regulator of proneural bHLH proteins including Achaete
and Scute and is a negative regulator of neurogenesis so that
emc mutants exhibit ectopic neural differentiation (Ellis et al.,
1990; Garrell andModolell, 1990). Figure 1 summarizes the basic
outline of HLH function in cell-type specification and differentia-
tion, in which specific expression of particular class II bHLH pro-
teins must compete with ID proteins to heterodimerize with
E proteins and form tissue- and cell-type-specific transcription
factors that drive specification and differentiation. bHLH proteins
are now known to regulate differentiation in too many additional
situations to be listed here. For example, E proteins and ID pro-
teins regulate Sertoli cell differentiation (Chaudhary et al., 2005),
possibly through the class II bHLH proteins POD1/Epicardin
(TCF21) and Scleraxis (Muir et al., 2006; Bhandari et al., 2011).
Expression of Da, the only E protein, inDrosophila seems to be
ubiquitous, whereas particular mammalian E protein and ID pro-
tein genes have various overlapping patterns of expression. Id1
and Id3 in particular are often upregulated by BMP signals, and
Id1 by cytokines (Ling et al., 2014). TGFb,FGF and TCR signaling
also regulate Id gene expression (Lasorella et al., 2014; Ling
et al., 2014). Both Drosophila and mammals exhibit cross-talk
between ID proteins and Notch signaling, consistent with their
common regulation of bHLH-mediated differentiation (Baonza
et al., 2000; Adam and Montell, 2004; Bhattacharya and Baker,
2009; Lasorella et al., 2014; Ling et al., 2014). It is increas-
ingly recognized that Id genes can be transcriptional targets ofDevelopmental Cell 35, November 9, 2015 ª2015 Elsevier Inc. 269
Table 1. HLH Protein Nomenclature
Protein Name Old Gene Name New Gene Name
E12, E47 E2A TCF3
E2-2 E2-2 TCF4
HEB HEB TCF12
Figure 1. Transcriptional Modalities of HLH Proteins
(A) Transcriptional activation of Drosophila proneural genes requires the
ubiquitously expressed E protein (Da) forming heterodimers with tissue-
specific bHLH proteins (e.g., Ac/Sc) and binds to promoter E boxes.
(B) Transcription of myogenic genes is controlled by the binding of E protein-
myogenic-specific bHLH protein (MyoD) heterodimers to promoter E boxes.
(C) E protein (or Da) and ID (or Emc) protein heterodimers fail to bind DNA and
cannot activate transcription.
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teins feedback inhibitors of E protein activity, which may be
particularly important as a brake on E protein autoregulation
(Bhattacharya and Baker, 2011; Schmitz et al., 2012) (Figure 2).
ID proteins are also regulated at the level of protein stability
(Lingbeck et al., 2005; Lasorella et al., 2006; Kim et al., 2009;Wil-
liams et al., 2011b; Lasorella et al., 2014).
Since mouse knockouts of each of the E proteins and ID pro-
teins have mutant phenotypes, neither E proteins nor ID proteins
can be completely redundant. The example of Id1 and Id3 double
null (Id1/; Id3/) mice, which exhibit premature neuronal dif-
ferentiation, forebrain vascular abnormalities, cardiac defects,
and embryonic lethality not seen in the single mutants (Lyden
et al., 1999; Lasorella et al., 2014), illustrates significant functional
overlap thatmay also occur for other ID proteins and similarly be-
tweenEproteins (Table 2).Non-overlappingexpressionaccounts
for some non-redundancy, although unique protein functions
may also exist, especially in the case of E proteins that differ in
basic region sequence andDNA-binding preference. It is thought
that any unique functions of individual proteins are superimposed
on the overall ratio of total E proteins to total ID proteins within a
cell that is an important indexof competence indifferentiationand
other processes. For example, elevating Da levels, which are
controlled by feedback through Emc, affects the capacity of
Ato or Sc to induce neurons in Drosophila (Bhattacharya and
Baker, 2011), and elevated E protein levels are thought to act
similarly in the postnatal mouse brain (Fischer et al., 2014).
HLH Proteins in the Cell Cycle and Senescence
The commitment of progenitor cells to begin cell differentiation is
often associated with cell-cycle withdrawal. MYOD provided the
first example connecting bHLH proteins to cell-cycle arrest, in-
hibiting cell cycling as myoblasts differentiate (Gu et al., 1993;
Halevy et al., 1995; Guo et al., 1995; Zhang et al., 1999). Subse-
quent studies have uncovered a common relationship between
E and ID proteins and cell-cycle progression. In many cells,
E12 or E47 homodimers activate transcription of the CDK inhib-
itors (CDKIs) p15, p16 (also known as INK4a), p21, p27, and p57
(Sloan et al., 1996; Prabhu et al., 1997; Pagliuca et al.,
2000)(Figure 3). Through this mechanism, E proteins inhibit
cell-cycle progression and are also implicated in cellular senes-
cence (Ling et al., 2014). In fact, E47 is necessary for senescence
of human fibroblasts, which is prevented by E protein knock-
down (Zheng et al., 2004).
As one might expect, the role of E proteins is blocked by ID
proteins (Peverali et al., 1994). ID proteins can promote retino-
blastoma (RB) protein inactivation and activate E2F-mediated
transcription and cell-cycle progression indirectly because of
their inhibition of E proteins and consequently inhibition of
CDKIs’ expression, while ID2 can be sequestered by RB directly
(Lasorella et al., 2014; Ling et al., 2014) (Figure 3). ID1 and ID3 are
degraded during senescence (Kong et al., 2011). ID proteins270 Developmental Cell 35, November 9, 2015 ª2015 Elsevier Inc.regulate proliferation in many important tissues, for example,
during the expansion of mammary epithelia during pregnancy
(de Candia et al., 2004). Because of their dual effects on differen-
tiation and proliferation, ID protein expression is associated with
stem cell maintenance, and, in tumors, anaplasia (Nam and Ben-
ezra, 2009; Anido et al., 2010; Barrett et al., 2012; Niola et al.,
2012; Lasorella et al., 2014; Ling et al., 2014; Nair et al., 2014).
Although this general relationship is seen in many cells, there
are examples of different effects. Id1 is reported to protect
mammary epithelia cells from senescence independently of
CDKI expression (Swarbrick et al., 2008), and rapidly dividing
transit amplifying cells surprisingly express less Id1 than their
quiescent neural stem cell progenitors (Nam and Benezra,
2009). The poor growth of Drosophila cells lacking emc is
also due to Da hyperactivity, not attributed to CDKI expression
but to repression of the phosphatase Cdc25/string or to over-
expression of the gene expanded within the Salvador-Warts-
Hippo pathway of tumor suppressors (Bhattacharya and Baker,
2011; Andrade-Zapata and Baonza, 2014; Wang and Baker,
2015) (Figure 4). It is also envisaged that ID functions indepen-
dent of dimerization with HLH proteins may exist (Ling et al.,
2014).
Figure 2. Autoregulation and Feedback Inhibition in Normal and
Disease Conditions
(A) Emc expression requires Da activity. Once Emc level is upregulated, it will in
turn block autoregulation of da andDa activity (Bhattacharya andBaker, 2011).
This regulation may ensure the steady state of E protein and ID protein levels in
normal progenitor cells.
(B) ID proteins are transcriptional targets of E proteins in Burkitt lymphoma
cells. Both gain-of-function mutations of E protein (indicated by + symbol) and
loss-of-functionmutations of ID protein (indicated by X symbol) found in Burkitt
lymphoma interrupt the feedback network between E and ID proteins. Cyclin
D3 is also a target gene of E proteins in Burkitt lymphoma cells and may
contribute to the excessive proliferation of tumor cells (Schmitz et al., 2012).
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There is a well-established connection between cancer and E
proteins (Murre, 2005; Belle and Zhuang, 2014). In addition to
lymphoma predisposition in E2a/Tcf3 mutant mice, E2A/TCF3
mutations have been found in many human lymphomas and leu-
kemias (Murre, 2005; Tijchon et al., 2013; Belle and Zhuang,
2014; Cozen et al., 2014). As would be expected, ID proteins
mostly have the opposite properties (Lasorella et al., 2014; Nair
et al., 2014). ID levels are elevated in human tumors ranging
from melanoma to neuroblastoma (Perk et al., 2005). ID1 and
ID3 are clearly implicated in lung cancer initiation, and ID4 is
overexpressed by a t(6;14)(p22;q32) chromosomal translocation
in leukemia and amplified in ovarian cancer, qualifying it as a
proto-oncogene (Perk et al., 2005; Lasorella et al., 2014; Nair
et al., 2014).
No doubt many oncogenic and tumor suppressor roles of ID
proteins and E proteins reflect their roles in cell proliferation,
stemness, and senescence, but there are also contributions tometastasis and angiogenesis(Slattery et al., 2008; Lasorella
et al., 2014; Ling et al., 2014; Nair et al., 2014). ID proteins are
required to maintain glioma stem cells in the perivascular niche
by inhibiting E protein transcription of the RAP1GAP gene, since
RAP1 controls cancer stem cell adhesion to the niche through in-
tegrin signaling (Niola et al., 2013). Unexpectedly, ID3 and ID4
sometimes behave as tumor suppressors (Yu et al., 2005;
Chen et al., 2011; Love et al., 2012; Richter et al., 2012; Schmitz
et al., 2012). For example, recurrent mutations in the E47 (TCF3)
and ID3 genes occur in Burkitt’s lymphoma and may allow unre-
strained E47 expression to activate both cyclin D3 and PI3K sur-
vival signaling (Love et al., 2012; Richter et al., 2012; Schmitz
et al., 2012) (Figure 2B).
Postmitotic ID Functions: Neuronal Morphogenesis
In addition to roles in cell fate specification and in the regulation
of the cell cycle and senescence, in postmitotic neurons ID1, ID2
and ID4 are ubiquitinated by the Anaphase Promoting Complex/
Cyclosome (APC/C), and their subsequent turnover affects axon
and dendrite development (Lasorella et al., 2006; Kim et al.,
2009). Mutations of the APC/C interaction motif of ID2 enhance
axonal growth in mouse cerebellar granule neurons both
in vitro and in the cerebellar cortex, suggesting that ID2 de-
gradation maintains axon morphology by restraining E protein-
dependent axon growth (Lasorella et al., 2006). On the other
hand, knockdown of Id1 in the cerebellar cortex or primary hip-
pocampal neurons stimulates dendrite morphogenesis, indi-
cating an inhibitory role of ID1 in dendrite development (Kim
et al., 2009). APC/C is important in cell-cycle exit (Peters,
2006) and therefore might couple cell-cycle exit to dendrogene-
sis in differentiating neurons. It remains unknown at present
whether ID protein downregulation contributes to terminal cell-
cycle withdrawal in neurons and how E proteins affect dendrites.
These questions are of considerable interest, as neurological
disorders are associated with ID and E proteins (see below).
Beyond Developmental Defects and Cancer:
Connections to Disease
E proteins and ID proteins have been implicated in a number of
human diseases, which may be related to the roles of E and ID
proteins in differentiation and cycle regulation, or perhaps reflect
other mechanisms (Table 3). It is interesting to catalog these
potential disease relationships because their wide range argues
persuasively that E and ID proteins represent central regulators
active in most or all cells, rather than ubiquitous heterodimer
partners of little intrinsic interest, and also so that gaps in knowl-
edge can be identified. The following summaries are ordered
according to the strength of the evidence linking to human
disease, beginning with unambiguous Mendelian genetic
disease in humans and progressing through other human data
to mouse models that are suggestive but for which direct evi-
dence in human disease is wanting.
Pitt-Hopkins Syndrome
Haploinsufficiency for the E protein transcription factor gene
E2-2/TCF4 due to heterozygous mutations or deletions is
responsible for Pitt-Hopkins syndrome (PTHS), an autosomal
dominant disorder characterized by severe intellectual disability,
global developmental delay, recurrent seizure, and hyperventila-
tion (Zweier et al., 2007; Amiel et al., 2007; Giurgea et al., 2008;Developmental Cell 35, November 9, 2015 ª2015 Elsevier Inc. 271
Table 2. Phenotypes of HLH Protein Knockout Mice
Genotype Phenotype References
E2a(Tcf3)/ disrupted B cell development; lymphopoietic developmental
defects with high frequency of T cell lymphomas
Belle and Zhuang, 2014
Heb(Tcf12)/ reduced pro-B cells; developmental arrest of thymocyte
development
Zhuang et al., 1996
E2-2(Tcf4)/ reduced pro-B cells; normal mammary gland development;
abnormal hindbrain development in the pontine nucleus
Zhuang et al., 1996; Flora et al., 2007;
Itahana et al., 2008
Id1/ altered lipid and glucose metabolism; osteoporotic phenotype;
normal mammary gland development; impaired cancer stem
cell properties in glioma
de Candia et al., 2004; Chan et al., 2009;
Satyanarayana et al., 2012; Lasorella et al., 2014
Id2/ altered lipid and glucose metabolism; hydronephrosis (smooth
muscle hypertrophy at the ureteropelvic junction); Parkinson’s
disease-like features (impaired dopaminergic system); reduced
proliferation in mammary epithelia (lactation defect); reduced
body size; absence of lymph nodes and Peyer’s patches; absence
of NK cells and Langerhans cells
Aoki et al., 2004; de Candia et al., 2004;
Havrda et al., 2008; Park et al., 2008;
Hou et al., 2009; Mathew et al., 2013;
Tripathi et al., 2012; Havrda et al., 2013;
Lasorella et al., 2014
Id3/ symptoms of Sjo¨gren’s syndrome (impaired tear and saliva secretion
due to defective autoimmune system); normal mammary gland
development
de Candia et al., 2004; Li et al., 2004
Id4/ premature neuronal differentiation; altered lipid and glucose
metabolism; reduce osteoblast differentiation; enhance adipocyte
differentiation; reduced proliferation and increased apoptosis
in mammary cells
Dong et al., 2011; Murad et al., 2010;
Tokuzawa et al., 2010; Lasorella et al., 2014
Id1/ Id3/ premature neuronal differentiation; cardiac developmental defects;
brain vascular abnormalities; embryonic lethality
Lyden et al., 1999; Lasorella et al., 2014
Id1/+ Id3/ decreases of proliferation and mineralization in osteoblasts; vascular
defects and growth failure in tumor cell xenografts and genetic
models of cancer
Maeda et al., 2004; Lasorella et al., 2014
Id3/ApoE/ or
Id3/ Ldlr/
enhanced atherosclerosis Doran et al., 2010; Lipinski et al., 2012
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patients disrupt E2-2/TCF4 transcriptional activity (Forrest
et al., 2012; Sepp et al., 2012). In the developing and mature
CNS, E2-2/TCF4 is a heterodimer partner for class II bHLH pro-
neural and neuronal precursor proteins. Hence, heterozygous
loss of function affects a large number of target genes, including
the neuronal adhesion receptor genes contactin associated
protein-like 2 (CNTNAP2) and neurexin 1 (NRXN1) (Forrest
et al., 2012). Both CNTNAP2 and NRXN1 mutations have been
associated with PTHS-like disorder, schizophrenia, and autism
(Alarco´n et al., 2008; Zweier et al., 2009; Kirov et al., 2009).
PTHS could reflect: defective expression of such neuronal differ-
entiation genes that depend on E2-2/proneural gene hetero-
dimers; defective cell-cycle withdrawal (since cell-cycle re-entry
can be associated with defective neuronal differentiation;
Ruggiero et al., 2012); or defects in dendrite and axon morpho-
genesis. It is also noteworthy that a particular E2-2/TCF4 muta-
tion has been found in Rett syndrome (see below), suggesting
that related molecular mechanisms lead to PTHS and Rett
syndrome.
Fuchs Corneal Dystrophy
Multiple single nucleotide polymorphisms (SNPs) in E2-2/TCF4
are associated with Fuchs corneal dystrophy (Baratz et al.,
2010; Forrest et al., 2014; Lau et al., 2014), a common, domi-
nant, progressive, late onset disease in which endothelial cells
are gradually lost from the internal surface of the cornea. The272 Developmental Cell 35, November 9, 2015 ª2015 Elsevier Inc.hallmark of this disease is the increasing density of tiny bumps,
termed guttae, that form on the cornea, loss of the fluid-pump-
ing function of the endothelium cells, decrease in corneal trans-
parency, and resultant loss of vision. The lack of Fuchs corneal
dystrophy in PTHS patients that have heterozygous loss-of-
function E2-2/TCF4 mutations suggests that Fuchs corneal
dystrophy might involve E2-2/TCF4 gain of function. Interest-
ingly, endothelial samples from Fuchs corneal dystrophy pa-
tients exhibit reduced ID1 expression, which could be another
route to elevate E2-2/TCF4 activity (Matthaei et al., 2014)
(Figure 1). Since corneal endothelium is normally non-prolifera-
tive, cell-cycle arrest is unlikely to cause disease, but altered
expression of senescence-related genes has been reported
(Matthaei et al., 2014). In Drosophila, elevated Da expression
can be toxic and activates the Salvador-Warts-Hippo pathway
of tumor suppressors (Wang and Baker, 2015), but it is not
known whether this occurs in Fuchs corneal dystrophy. A
different view is suggested, however, by studies of SNP
rs613872 associated with an intronic trinucleotide repeat
expansion (Breschel et al., 1997; Wieben et al., 2012). This
expansion causes mis-splicing and RNA toxicity, similar to
other trinucleotide expansion disorders such as myotonic dys-
trophy type 1 and 2, fragile X syndrome, and frontotemporal
dementia (Du et al., 2015). RNA toxicity affects expression of
many other genes, and the effects of this SNP might have little
to do with E2-2/TCF4 function.
Figure 3. Mammalian HLH Proteins and Cell-Cycle Control
Cell-cycle regulation involving HLH proteins in multiple ways. E protein-
mediated activation of the CDK inhibitors p16, p21, p27, and p57 is shown.
Cell-cycle arrest is promoted by these CDK inhibitors in G1-S transition, S,
and G2-M phases. This regulation is negatively modulated by ID proteins
through the association with E proteins. Rb can antagonize ID2 by direct
interaction.
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In addition to linkage to PTHS and Fuchs corneal dystrophy,
several SNPs in E2-2/TCF4 are significantly associated with
schizophrenia (Stefansson et al., 2009; Forrest et al., 2014;
Quednow et al., 2014). E2-2/TCF4 is also a target of microRNA
(miRNA) 137, which has been mapped as a schizophrenia sus-
ceptibility locus (Schizophrenia Psychiatric Genome-Wide Asso-
ciation Study (GWAS) Consortium, 2011;Wright et al., 2013), and
predicted to bind other miRNAs associated with schizophrenia,
autism, and other CNS disorders (Perkins et al., 2007; Talebiza-
deh et al., 2008). However, none of the variants affect the
E2-2/TCF4 protein, so how E2-2/TCF4 activity is affected in
schizophrenia remains uncertain (Williams et al., 2011a). This
has not been resolved by mouse studies. E2-2/Tcf4 homozy-
gous null (E2-2/) mice displayed abnormal hindbrain develop-
ment in the pontine nucleus (Flora et al., 2007) (Table 2). Pontine
nucleus development requires heterodimers of E2-2/TCF4 with
ATOH-1 (Flora et al., 2007). Thus, schizophrenia could have a
developmental origin caused by reduction of E2-2/TCF4 func-
tion. On the other hand, E2-2/TCF4 overexpressing transgenic
mice have defects in fear conditioning and sensorimotor gating
(Brzo´zka et al., 2010). Sensorimotor gating has been used for a
long time in animal model studies because it resembles the over-
sensitivity to sensory stimulation seen in schizophrenic patients
(Braff and Geyer, 1990). Clearly, it would be very informative to
resolve how schizophrenia-associated SNPs affect E2-2/TCF4function and how they differ from those associated with Fuchs
corneal dystrophy.
Rett Syndrome
Rett syndrome is an X-linked dominant disorder primarily
caused by loss-of-function mutations in the methyl-CpG-bind-
ing protein 2 (MeCP2) gene, which lead to intellectual disability
including language deficits, epileptic seizures, and respiratory
dysfunction (Bedogni et al., 2014). Microarray and chromatin
immunoprecipitation analyses identified ID1, ID2, ID3, and ID4
genes as primary targets of MeCP2 (Peddada et al., 2006).
MeCP2 is a repressor, and upregulation of all four IDs has
been found in MeCP2 null mouse brain (MeCP2-/Y hemizy-
gotes) as well as brain tissue from Rett syndrome patients
(Peddada et al., 2006). The MeCP2 null mutant mouse also
has reduced expression of the neural precursor gene NeuroD1
(Peddada et al., 2006). Since E47/TCF3 stimulates NeuroD1
transcription (Sharma et al., 1999), high ID protein levels could
reduce NeuroD1 expression. Interestingly, a frameshift muta-
tion of E2-2/TCF4 was recently discovered in a variant Rett
syndrome patient who did not have mutations in MeCP2
(Armani et al., 2012). E2-2/TCF4 loss of function is expected
to mimic effects of ID protein overexpression. Other E2-2/
TCF4 loss-of-function mutations cause Pitt-Hopkins syndrome
(see above), which shares symptoms with Rett syndrome.
Although the cellular basis of Rett syndrome is not yet clear,
altered neural differentiation as a consequence of reduced
NeuroD expression, defects in neuronal cell-cycle withdrawal,
or altered axon or dendrite morphogenesis are all plausible
candidates.
A further connection between HLH proteins and autism spec-
trum disorders is that ID3 has been reported as a target of miR-
29b, a brain-specific miRNA that is expressed more highly in
autism spectrum disorders. ID3 expression is significantly down-
regulated in miR-29b-transfected cells (Sarachana et al., 2010).
Whether ID3 is really involved in autism, whether its function in
this regard is related to that of E2-2/TCF4, and whether differen-
tiation, cell cycle, neuronal morphology, or other defects are
involved remain to be elucidated. Intriguingly, one trait that is
strongly associated with autism is circadian rhythm dysfunction
(Hu et al., 2009). ID proteins play essential roles in controlling
circadian rhythm by sequestering the bHLH transcription factors
CLOCK and BMAL that are central components of the circadian
pacemaker (Duffield et al., 2009).
Atherosclerosis
ID3 maps to atherosclerosis susceptibility loci in both humans
and mice (Lusis et al., 2004). A SNP (rs11574) substitutes Thr
for Ala105 in the human ID3 protein and is associated with
increased carotid intima-media thickness (IMT) (Doran et al.,
2010). This mutation decreases ID3 function as measured by
binding to E12 in NIH 3T3 cells (Doran et al., 2010).
Atherosclerosis is strongly enhanced when Id3 is deleted in
ApoE or Ldlr knockout mice (i.e., in Id3/ ApoE/ or Id3/
Ldlr/ genotypes) (Doran et al., 2010; Lipinski et al., 2012)
(Table 2). Bone marrow transplantation from Id3+/+ ApoE/
donors is atheroprotective, pointing to a role in bone marrow-
derived cell types (Doran et al., 2012). These mice have
reduced B cell numbers but increased macrophage numbers
in the aorta (Doran et al., 2012; Lipinski et al., 2012). Chemo-
kines and vascular cell adhesion molecule 1 (VCAM-1) areDevelopmental Cell 35, November 9, 2015 ª2015 Elsevier Inc. 273
Figure 4. Drosophila HLH Proteins in
Growth Control
When Drosophila ID protein (emc) is mutated,
excess Drosophila E protein (Da) homodimers
activate expanded (ex) transcription via binding to
E boxes in the cis-regulatory element. The sub-
sequent activation of Salvador-Warts-Hippo
signaling pathway inhibits Yki/YAP activity,
thereby blocking cell growth and survival. High
levels of Da are also involved in blocking cell-cycle
progression in G2-M transition through inhibiting
stg/cdc25 transcription (Andrade-Zapata and
Baonza, 2014; Wang and Baker, 2015).
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sion and recruitment into the arterial wall. The VCAM-1 pro-
moter is regulated by E12 and could be activated by E12
following a reduction in ID3 (Lipinski et al., 2012). One model,
therefore, is that ID3 protects against atherosclerosis by
altering leukocyte recruitment to artery walls (Doran et al.,
2010; Lipinski et al., 2012; Doran et al., 2012).
The effect of ID proteins on the vasculature is complicated,
however (Yang et al., 2014). ID3 inhibits adiponectin expression
by preventing E47 from binding to E boxes in the adiponectin
promoter (Doran et al., 2008). Adiponectin is an adipocyte-
derived cytokine that attenuates plaque formation: low adipo-
nectin levels are associated with coronary artery disease,
whereas adiponectin overexpression reduced atherosclerosis
in ApoE-deficient mice. Atherosclerosis might also be impacted
by the roles of ID proteins in vascular smooth muscle cells and
endothelial cells (see below). For example, alternative splicing
of Id3 in vascular lesions may produce a protein with a uniquely
atheroprotective role (Forrest et al., 2004).
Arterial Vascular Disease
Mutations in the BMPR2 gene that encodes the BMP type II re-
ceptor are found inmost cases of heritable pulmonary arterial hy-
pertension (PAH), in which smooth muscle cells proliferate to
occlude the vessel (Lane et al., 2000; Machado et al., 2006).
ID1 and ID3 are targets of BMP signaling in pulmonary artery
smooth muscle cells, as in other cell types, and a recent study
suggests that ID proteins mediate anti-proliferative effect of
BMP signaling (Yang et al., 2013). The mechanism is unclear,
however, because both Id2 and Id3 are also reported to inhibit
p21 expression in proliferating vascular smooth muscle cells,
as in many other cell types (Matsumura et al., 2002; Forrest
et al., 2004; Taylor et al., 2006) (Figure 3). ID proteins also have
roles in endothelial cells (Ling et al., 2014; Yang et al., 2014).
Id1/;Id3/mice exhibit cardiac developmental defects, brain274 Developmental Cell 35, November 9, 2015 ª2015 Elsevier Inc.vascular abnormalities, and embryonic
lethality (Lyden et al., 1999) (Table 2).
Bone Marrow Failure
A connection between HLH proteins and
bone marrow failure has been suggested
based only on ID2 upregulation and E47
and HEB/TCF12 downregulation in Dia-
mond Blackfan anemia (DBA) patients
(Zhang et al., 1997). E47/TCF3, HEB/
TCF12, and a tissue-restricted expressed
bHLH protein, SCL, regulate earlyerythroid differentiation and are reduced during maturation
when ID2 is upregulated so that elevated ID2 would be
expected to decrease the expression of erythroid specific genes
and erythroid differentiation. This could be re-evaluated now that
it is known that approximately 65% of patients harbor mutations
in ribosomal protein genes (Farrar et al., 2011) and that many
aspects of DBA have been attributed to p53 hyperactivity
caused by nucleolar stress (Ellis, 2014). Although p53 can regu-
late ID1 and ID2 transcription in neural stem cells, repression is
observed, contrary to the notion that ID2 is upregulated in DBA
patients (Paolella et al., 2011). It is not impossible that differenti-
ation defects can contribute to DBA, however, as suggested by
mutations in the hematopoietic transcription factor GATA1 that
were recently found in some DBA cases (Sankaran et al., 2012).
Diabetes, Glucose, and Lipid Metabolism
Insulin affects glucose and lipid metabolism, and both are dis-
rupted in diabetes. b cells in the islets of Langerhans of diabetic
mice or isolated b cells exposed to hyperglycemia or lipid have
elevated ID1/ID3 expression (Wice et al., 2001; Busch et al.,
2002; Kjørholt et al., 2005; Billestrup, 2011). Consistent with
the notion that ID proteins impair glucose and lipid metabolism,
islets from Id1/ mice are protected against high-fat diet-
induced repression of b cell genes, such as pancreatic duodenal
homeobox-1, NeuroD1 (also called Beta2), Glut2, pyruvate
carboxylase, and Gpr40 (Akerfeldt and Laybutt, 2011). Id1/
mice show less insulin resistance in skeletal muscle, liver, and
white adipose tissue and increased Uncoupling Protein 1 and
Peroxisome proliferator-activated receptor gamma coactivator
1 in brown adipose tissue (corresponding to increased energy
expenditure) (Satyanarayana et al., 2012). Mice overexpressing
E proteins revealed similar phenotypes (Zhao et al., 2014).
Although Id1 expression is downregulated and the protein
apparently degraded during adipocyte differentiation, adipogen-
esis appears normal in Id1/ mice, suggesting that it is effects
Table 3. HLH Protein Diseases and Mechanisms
Disease
Affected Organ or
Tissue HLH Protein Evidence Process Affected
Pitt-Hopkins syndrome brain, face E2-2/TCF4 human mutation differentiation? cell cycle?
neuronal morphogenesis?
Fuchs corneal dystrophy eye E2-2/TCF4 human gene association senescence?
Schizophrenia brain E2-2/TCF4 human gene association differentiation? cell cycle?
neuronal morphogenesis?
Rett syndrome brain E2A/TCF3, ID1–4 gene expression differentiation? cell cycle?
neuronal morphogenesis?
Atherosclerosis arteries E2A/TCF3, ID3 human, mouse gene
association
differentiation?
Diamond Blackfan anemia bone marrow E2A/TCF3,
HEB/TCF12, ID2
gene expression differentiation?
Diabetes, glucose and
lipid metabolism
multiple ID1-2,4 mouse mutant models differentiation?
Osteoporosis bone ID1, ID4 mouse mutant models differentiation?
Arterial vascular disease arteries ID1, ID3 mouse mutant models cell cycle?
Congenital hydronephrosis kidney ID2 mouse mutant models differentiation?
Polycystic kidney disease kidney E2A/TCF3, ID2 gene expression cell cycle?
Parkinson’s disease brain, nerves ID2 mouse mutant models differentiation?
Sjogren’s syndrome lachrymal, salivary
glands, skin
ID3 mouse mutant models differentiation?
Developmental Cell
Reviewon oxygen consumption and thermogenesis that protect them
against a high-fat diet (Satyanarayana et al., 2012). E2A/TCF3
and E2-2/TCF4 proteins can also directly increase insulin
expression in b cells (Vierra and Nelson, 1995).
Other ID proteins also regulate metabolism. Mice with homo-
zygous deletions of Id2 or Id4 have less body fat and gain
much less weight on a high-fat diet (Murad et al., 2010; Mathew
et al., 2013). Id2/mice have altered lipid metabolism, impaired
adipogenesis, and reduced gonadal white adipose deposits and
liver lipid content (Park et al., 2008; Hou et al., 2009; Mathew
et al., 2013) (Table 2). Male Id2/mice also reveal increased in-
sulin sensitivity, increased glucose uptake by skeletal muscle
and brown adipose tissue, and reduced intramuscular triacylgly-
cerol and diacylglycerol levels (Mathew et al., 2013). Apparently,
therefore, ID1, 2, and 4 play a variety of roles in insulin secretion
and energy metabolism.
Osteopenia and Osteoporosis
Id1/ mice have an osteoporotic phenotype, i.e., reduced bone
density and increased bone fragility (Chan et al., 2009) (Table 2).
Healthy bone volume is controlled by the balance between bone
deposition by osteoblasts and bone resorption by osteoclasts.
Excess of bone resorption over bone formation results in
osteoporosis and its milder potential precursor, osteopenia.
Osteoclasts and osteoblasts are derived from distinct lineages:
osteoclasts differentiate from hematopoietic stem cell (HSC)
precursors (Suda et al., 1992), while osteoblasts arise
from mesenchymal stem cells (MSCs). The bone phenotype of
Id1/ is due to excess osteoclastogenesis (Chan et al., 2009).
Genes required for osteoclastogenesis are upregulated, including
Trap, Oscar, and Ctsk; overexpressing ID1 downregulates these
genes (Chan et al., 2009). It would be reasonable to anticipate a
positive role of one ormore E proteins in osteoclast differentiation
and maturation, although none seems to have been reported.Osteoporosis and age-related osteopenia also result from dif-
ferentiation of MSCs into bone marrow adipocytes rather than
osteoblasts. Adipocytes additionally suppress osteogenesis
because secreted adipogenic signals influence osteoclast differ-
entiation by HSCs. Id4/mice reduce osteoblast differentiation
and enhance adipocyte differentiation (Tokuzawa et al., 2010)
(Table 2). ID4 competes with the bHLH factor Hes1 to dimerize
with Hey2, allowing Hes1 to activate osteoblast-specific gene
transcription and to promote osteogenesis through the key oste-
oblast differentiation factor Runx2 (Tokuzawa et al., 2010). It is
not known how Hes1 regulates Runx2 levels (Ikawa et al.,
2006). Other ID proteins also affect osteoblasts, which show
reduced proliferation and mineralization in Id1+/; Id3/ mice
(Maeda et al., 2004). Taken together, these findings make both
ID and perhaps E proteins potential targets for the prevention
and treatment of osteoporosis because of their roles in osteo-
clast and osteoblast specification.
Renal Disease
Id2+/ or Id2/mice develop congenital hydronephrosis, which
is common in humans and may result in early-onset renal failure
(Aoki et al., 2004; Tripathi et al., 2012). The cause of hydroneph-
rosis is frequently obstruction at the ureteropelvic junction.
Id2 mutant mice display irregular, hypertrophic muscle layers
at the ureteropelvic junction, suggesting that smooth muscle
hypertrophy at the ureteropelvic junction could be the cause of
hydronephrosis (Aoki et al., 2004). E protein-dependent myo-
genesis could be stimulated when ID2 levels are decreased,
but the usual role of E proteins is to inhibit proliferation, not pro-
mote it (Figures 1 and 3).
A role for ID proteins was also suggested in autosomal domi-
nant polycystic kidney disease (PKD), which is mostly caused by
mutations in the PKD1 and PKD2 genes (Peters and Sandkuijl,
1992). In this disease, bilateral renal cysts replace the normalDevelopmental Cell 35, November 9, 2015 ª2015 Elsevier Inc. 275
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Cysts are lined by a single layer of epithelium that is character-
ized by increased cellular proliferation and decreased differenti-
ation (Nadasdy et al., 1995). It was reported that Polycystin-2,
the product of the PKD2 gene, sequestered ID2 in the cytoplasm
in a PKD1-dependent manner, suppressing inappropriate prolif-
eration through E47-dependent p21 transcription (Li et al., 2005;
Zhou, 2009). More recent publications focus on defects in Ca2+
regulation at the cilium as a cause of PKD, however, and the rela-
tionship to cell-cycle regulation by ID and E proteins is unclear
(Fliegauf et al., 2007; Fedeles et al., 2011).
Parkinsonism
Id2 homozygous null mutant mice display features of Parkin-
son’s disease, such as fewer dopaminergic neurons in the olfac-
tory bulb and reduced olfactory discrimination (Havrda et al.,
2008). Id2/ mice also have reduced dopamine transporter
expression, activated caspase-3, as well as glial infiltration in
the substantia nigra pars compacta of brain (Havrda et al.,
2013) (Table 2). These observations suggest that ID2 is required
for the development ofmidbrain dopaminergic neurons and raise
the question of how ID2might be involved in Parkinson’s disease
and other disorders of the dopaminergic system such as atten-
tion deficit hyperactivity disorder, schizophrenia, and drug
abuse. Intriguingly, significant inductions of ID1, ID2, and ID3
expression by decreased dopamine levels have been detected
in rodents under continuous stress conditions (Konishi et al.,
2010). At present, it is not knownwhether E proteins play specific
roles in dopaminergic neurons, other than their general role in
neuronal differentiation (Figure 1).
Sjogren’s Syndrome
ID3 homozygous null (Id3/) mice develop many symptoms
similar to those found in Sjo¨gren’s syndrome, an autoimmune
disease in which immune cells chronically attack the lachrymal
and salivary glands, resulting in impaired tear and saliva secre-
tion (Li et al., 2004) (Table 2). The effect of Id3 gene inactivation
may be on lymphocyte differentiation because adoptive transfer
of Id3/ bone marrow cells is sufficient to induce symptoms of
Sjo¨gren’s syndrome (Li et al., 2004; Guo et al., 2011) and
because CD20 antibody treatment, which depletes B cells, re-
lieves the Sjo¨gren’s symptoms of Id3/ mice (Hayakawa
et al., 2007). Since ID3 is required to downregulate E proteins
during T cell development, defective T cells may also contribute
to the disease (Engel andMurre, 2002; Kim et al., 2002). Although
no changes in ID3 mRNA levels have been seen in T cells from
human patients, it remains an interesting possibility that defects
in E protein-dependent lymphocyte differentiation contribute to
Sjo¨gren’s syndrome (Ling et al., 2014).
Conclusions and Prospects
Although genetic evidence in humans directly implicates E and
ID proteins in Pitt-Hopkins syndrome, schizophrenia, Rett syn-
drome, atherosclerosis, and perhaps Fuchs corneal dystrophy
and pulmonary arterial hypertension, how these diseases are
related to the well-studied roles of E and ID proteins in normal
development is not yet clear. More information would be useful
to substantiate the contributions of E and ID proteins to Diamond
Blackfan anemia and polycystic kidney disease. At the moment,
changes in E proteins or ID proteins are not implicated as direct
causes of defects in metabolism or diabetes, bone fragility, hy-276 Developmental Cell 35, November 9, 2015 ª2015 Elsevier Inc.dronephrosis, Parkinsonism, or Sjogrens’ syndrome in humans,
but their mouse mutations provide models of these disorders
and suggest they may be involved. This variety of diseases
and models reinforces the notion that E and ID proteins and their
relative expression levels constitute an important aspect of the
cellular regulatory environment that remains important
throughout life, not only during early development. The mecha-
nisms established for HLH protein regulation in normal develop-
ment provide a useful starting point for disease mechanisms
(Figures 1 and 2). For example, do ID proteins regulate dendrite
growth through E proteins and transcription, and is this relevant
to neurological conditions? More still remains to be learned
concerning normal E and ID protein expression and function,
especially at the post-transcriptional level. Post-translational
modification and changes in subcellular localization have all
been reported (Lingbeck et al., 2005; Kurooka and Yokota,
2005; Sun et al., 2005; Rollin et al., 2009; Nio-Kobayashi et al.,
2013; Lasorella et al., 2014). Protein turnover and stability may
be a regulatory factor and therapeutic target. Recent work
shows that the Drosophila E protein Da is destabilized by Notch
signaling, and this may be one of the mechanisms by which
Notch regulates so many differentiation processes (Kiparaki
et al., 2015). These studies exemplify the broad effects and po-
tential therapeutic opportunities expected to accrue frommodu-
lating these very widely expressed and important HLH proteins.ACKNOWLEDGMENTS
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